Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

Mariangela Soberón Felín; Kanix Wang; Catalina Raggi; Aliya Moreira; Abhinav Pandey; Andrew Grose; Zuleima Caballero; Claudia Rengifo-Herrera; Margarita Ramirez; Davina Moossazadeh; Catherine Castro; José Luis Sanchez Montalvo; Karen Leahy; Ying Zhou; Fatima Alibana Clouser; Maryam Siddiqui; Nicole Leong; Perpetua Goodall; Morgan Michalowski; Mahmoud Ismail; Monica Christmas; Stephen Schrantz; Ximena Norero; Dora Estripeaut; David Ellis; Kevin Ashi; Samantha Dovgin; Ashtyn Dixon; Xuan Li; Ian Begeman; Sharon Heichman; Joseph Lykins; Delba Villalobos-Cerrud; Lorena Fabrega; Connie Mendivil; Mario R. Quijada; Silvia Fernández-Pirla; Valli de La Guardia; Digna Wong; Mayrene de LadrónGuevara; Carlos Flores; Jovanna Borace; Anabel García; Natividad Caballero; Maria Theresa Moreno de Saez; Michael Politis; Stephanie Ross; Mimansa Dogra; Vishan Dhamsania; Nicholas Graves; Marci Kirchberg; Kopal Mathur; Ashley Aue; Carlos M. Restrepo; Alejandro Llanes; German Guzman; Arturo Rebollon; Kenneth Boyer; Peter Heydemann; A. Gwendolyn Noble; Charles Swisher; Peter Rabiah; Shawn Withers; Teri Hull; Chunlei Su; Michael Blair; Paul Latkany; Ernest Mui; Daniel Vitor Vasconcelos-Santos; Alcibiades Villareal; Ambar Perez; Carlos Andrés Naranjo Galvis; Mónica Vargas Montes; Nestor Ivan Cardona Perez; Morgan Ramirez; Cy Chittenden; Edward Wang; Laura Lorena Garcia-López; Juliana Muñoz-Ortiz; Nicolás Rivera-Valdivia; María Cristina Bohórquez-Granados; Gabriela Castaño-de-la-Torre; Guillermo Padrieu; Juan David Valencia Hernandez; Daniel Celis-Giraldo; John Alejandro Acosta Dávila; Elizabeth Torres; Manuela Mejia Oquendo; José Y. Arteaga-Rivera; Dan Nicolae; Andrey Rzhetsky; Nancy Roizen; Eileen Stillwaggon; Larry Sawers; Francois Peyron; Martine Wallon; Emanuelle Chapey; Pauline Levigne; Carmen Charter; Migdalia De Frias; Jose Montoya; Cindy Press; Raymund Ramirez; Despina Contopoulos-Ioannidis; Yvonne Maldonado; Oliver Liesenfeld; Carlos Gomez; Kelsey Wheeler; Ellen Holfels; David Frim; David McLone; Richard Penn; William Cohen; Samantha Zehar; James McAuley; Denis Limonne; Sandrine Houze; Sylvie Abraham; Raphael Piarroux; Vera Tesic; Kathleen Beavis; Ana Abeleda; Mari Sautter; Bouchra El Mansouri; Adlaoui El Bachir; Fatima Amarir; Kamal El Bissati; Alejandra de-la-Torre; Gabrielle Britton; Jorge Motta; Eduardo Ortega-Barria; Isabel Luz Romero; Paul Meier; Michael Grigg; Jorge Gómez-Marín; Jagannatha Rao Kosagisharaf; Xavier Sáez Llorens; Osvaldo Reyes; Rima McLeod

doi:10.1007/s40124-022-00265-0

Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

Título traducido de la contribución: Creación de programas para erradicar la toxoplasmosis Parte III: Epidemiología y factores de riesgo

Mariangela Soberón Felín, Kanix Wang, Catalina Raggi, Aliya Moreira, Abhinav Pandey, Andrew Grose, Zuleima Caballero, Claudia Rengifo-Herrera, Margarita Ramirez, Davina Moossazadeh, Catherine Castro, José Luis Sanchez Montalvo, Karen Leahy, Ying Zhou, Fatima Alibana Clouser, Maryam Siddiqui, Nicole Leong, Perpetua Goodall, Morgan Michalowski, Mahmoud IsmailMonica Christmas, Stephen Schrantz, Ximena Norero, Dora Estripeaut, David Ellis, Kevin Ashi, Samantha Dovgin, Ashtyn Dixon, Xuan Li, Ian Begeman, Sharon Heichman, Joseph Lykins, Delba Villalobos-Cerrud, Lorena Fabrega, Connie Mendivil, Mario R. Quijada, Silvia Fernández-Pirla, Valli de La Guardia, Digna Wong, Mayrene de LadrónGuevara, Carlos Flores, Jovanna Borace, Anabel García, Natividad Caballero, Maria Theresa Moreno de Saez, Michael Politis, Stephanie Ross, Mimansa Dogra, Vishan Dhamsania, Nicholas Graves, Marci Kirchberg, Kopal Mathur, Ashley Aue, Carlos M. Restrepo, Alejandro Llanes, German Guzman, Arturo Rebollon, Kenneth Boyer, Peter Heydemann, A. Gwendolyn Noble, Charles Swisher, Peter Rabiah, Shawn Withers, Teri Hull, Chunlei Su, Michael Blair, Paul Latkany, Ernest Mui, Daniel Vitor Vasconcelos-Santos, Alcibiades Villareal, Ambar Perez, Carlos Andrés Naranjo Galvis, Mónica Vargas Montes, Nestor Ivan Cardona Perez, Morgan Ramirez, Cy Chittenden, Edward Wang, Laura Lorena Garcia-López, Juliana Muñoz-Ortiz, Nicolás Rivera-Valdivia, María Cristina Bohórquez-Granados, Gabriela Castaño-de-la-Torre, Guillermo Padrieu, Juan David Valencia Hernandez, Daniel Celis-Giraldo, John Alejandro Acosta Dávila, Elizabeth Torres, Manuela Mejia Oquendo, José Y. Arteaga-Rivera, Dan Nicolae, Andrey Rzhetsky, Nancy Roizen, Eileen Stillwaggon, Larry Sawers, Francois Peyron, Martine Wallon, Emanuelle Chapey, Pauline Levigne, Carmen Charter, Migdalia De Frias, Jose Montoya, Cindy Press, Raymund Ramirez, Despina Contopoulos-Ioannidis, Yvonne Maldonado, Oliver Liesenfeld, Carlos Gomez, Kelsey Wheeler, Ellen Holfels, David Frim, David McLone, Richard Penn, William Cohen, Samantha Zehar, James McAuley, Denis Limonne, Sandrine Houze, Sylvie Abraham, Raphael Piarroux, Vera Tesic, Kathleen Beavis, Ana Abeleda, Mari Sautter, Bouchra El Mansouri, Adlaoui El Bachir, Fatima Amarir, Kamal El Bissati, Alejandra de-la-Torre, Gabrielle Britton, Jorge Motta, Eduardo Ortega-Barria, Isabel Luz Romero, Paul Meier, Michael Grigg, Jorge Gómez-Marín, Jagannatha Rao Kosagisharaf, Xavier Sáez Llorens, Osvaldo Reyes, Rima McLeod

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

Resumen

Propósito de la revisión: Revisar datos exhaustivos sobre las tasas de toxoplasmosis en Panamá y Colombia. Hallazgos recientes: Se revisaron muestras y conjuntos de datos de Panamá y Colombia que facilitaron estimaciones sobre seroprevalencia de anticuerpos contra Toxoplasma y factores de riesgo. Resumen: A partir de estos datos se elaboraron mapas de cribado, mapas de seroprevalencia y modelos matemáticos de factores de riesgo. Los estudios realizados en Ciudad de Panamá estimaron la seroprevalencia entre el 22 y el 44%. Se encontraron relaciones consistentes entre las tasas de prevalencia más altas y factores como la pobreza y la proximidad a fuentes de agua. Las tasas de detección prenatal de anticuerpos antitoxoplasma fueron variables, a pesar de la existencia de una ley de detección. Los mapas de calor mostraron una correlación entre la proximidad a masas de agua y la seroprevalencia global de Toxoplasma. Los mapas epidemiológicos espaciales y los modelos matemáticos identifican las regiones específicas que más podrían beneficiarse de campañas sanitarias preventivas integrales relacionadas con la toxoplasmosis congénita y la infección por Toxoplasma.

Título traducido de la contribución	Creación de programas para erradicar la toxoplasmosis Parte III: Epidemiología y factores de riesgo
Idioma original	Inglés estadounidense
Páginas (desde-hasta)	109–124
Número de páginas	16
Publicación	Current Pediatrics Reports
Volumen	10
N.º	2022
DOI	https://doi.org/10.1007/s40124-022-00265-0
Estado	Publicada - jun. 22 2022

Áreas temáticas de ASJC Scopus

Pediatría, perinaltología y salud infantil

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1007/s40124-022-00265-0

Otros archivos y enlaces

Citar esto

Felín, M. S., Wang, K., Raggi, C., Moreira, A., Pandey, A., Grose, A., Caballero, Z., Rengifo-Herrera, C., Ramirez, M., Moossazadeh, D., Castro, C., Montalvo, J. L. S., Leahy, K., Zhou, Y., Clouser, F. A., Siddiqui, M., Leong, N., Goodall, P., Michalowski, M., ... McLeod, R. (2022). Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors. Current Pediatrics Reports, 10(2022), 109–124. https://doi.org/10.1007/s40124-022-00265-0

@article{50526b50ac9941658b0ebf0f70ab161a,

title = "Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors",

abstract = "Purpose of Review: Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings: Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies to Toxoplasma and risk factors, were reviewed. Summary: Screening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panam{\'a} estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasma antibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overall Toxoplasma seroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis and Toxoplasma infection.",

author = "Fel{\'i}n, {Mariangela Sober{\'o}n} and Kanix Wang and Catalina Raggi and Aliya Moreira and Abhinav Pandey and Andrew Grose and Zuleima Caballero and Claudia Rengifo-Herrera and Margarita Ramirez and Davina Moossazadeh and Catherine Castro and Montalvo, {Jos{\'e} Luis Sanchez} and Karen Leahy and Ying Zhou and Clouser, {Fatima Alibana} and Maryam Siddiqui and Nicole Leong and Perpetua Goodall and Morgan Michalowski and Mahmoud Ismail and Monica Christmas and Stephen Schrantz and Ximena Norero and Dora Estripeaut and David Ellis and Kevin Ashi and Samantha Dovgin and Ashtyn Dixon and Xuan Li and Ian Begeman and Sharon Heichman and Joseph Lykins and Delba Villalobos-Cerrud and Lorena Fabrega and Connie Mendivil and Quijada, {Mario R.} and Silvia Fern{\'a}ndez-Pirla and {de La Guardia}, Valli and Digna Wong and {de Ladr{\'o}nGuevara}, Mayrene and Carlos Flores and Jovanna Borace and Anabel Garc{\'i}a and Natividad Caballero and {de Saez}, {Maria Theresa Moreno} and Michael Politis and Stephanie Ross and Mimansa Dogra and Vishan Dhamsania and Nicholas Graves and Marci Kirchberg and Kopal Mathur and Ashley Aue and Restrepo, {Carlos M.} and Alejandro Llanes and German Guzman and Arturo Rebollon and Kenneth Boyer and Peter Heydemann and Noble, {A. Gwendolyn} and Charles Swisher and Peter Rabiah and Shawn Withers and Teri Hull and Chunlei Su and Michael Blair and Paul Latkany and Ernest Mui and Vasconcelos-Santos, {Daniel Vitor} and Alcibiades Villareal and Ambar Perez and Galvis, {Carlos Andr{\'e}s Naranjo} and Montes, {M{\'o}nica Vargas} and Perez, {Nestor Ivan Cardona} and Morgan Ramirez and Cy Chittenden and Edward Wang and {Lorena Garcia-L{\'o}pez}, Laura and Juliana Mu{\~n}oz-Ortiz and Nicol{\'a}s Rivera-Valdivia and Boh{\'o}rquez-Granados, {Mar{\'i}a Cristina} and Gabriela Casta{\~n}o-de-la-Torre and Guillermo Padrieu and Hernandez, {Juan David Valencia} and Daniel Celis-Giraldo and {Acosta D{\'a}vila}, {John Alejandro} and Elizabeth Torres and Oquendo, {Manuela Mejia} and Arteaga-Rivera, {Jos{\'e} Y.} and Dan Nicolae and Andrey Rzhetsky and Nancy Roizen and Eileen Stillwaggon and Larry Sawers and Francois Peyron and Martine Wallon and Emanuelle Chapey and Pauline Levigne and Carmen Charter and {De Frias}, Migdalia and Jose Montoya and Cindy Press and Raymund Ramirez and Despina Contopoulos-Ioannidis and Yvonne Maldonado and Oliver Liesenfeld and Carlos Gomez and Kelsey Wheeler and Ellen Holfels and David Frim and David McLone and Richard Penn and William Cohen and Samantha Zehar and James McAuley and Denis Limonne and Sandrine Houze and Sylvie Abraham and Raphael Piarroux and Vera Tesic and Kathleen Beavis and Ana Abeleda and Mari Sautter and {El Mansouri}, Bouchra and {El Bachir}, Adlaoui and Fatima Amarir and {El Bissati}, Kamal and Alejandra de-la-Torre and Gabrielle Britton and Jorge Motta and Eduardo Ortega-Barria and Romero, {Isabel Luz} and Paul Meier and Michael Grigg and Jorge G{\'o}mez-Mar{\'i}n and {Rao Kosagisharaf}, Jagannatha and Llorens, {Xavier S{\'a}ez} and Osvaldo Reyes and Rima McLeod",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = jun,

day = "22",

doi = "10.1007/s40124-022-00265-0",

language = "English (US)",

volume = "10",

pages = " 109–124",

journal = "Current Pediatrics Reports",

issn = "2167-4841",

publisher = "Springer Science and Business Media B.V.",

number = "2022",

}

Felín, MS, Wang, K, Raggi, C, Moreira, A, Pandey, A, Grose, A, Caballero, Z, Rengifo-Herrera, C, Ramirez, M, Moossazadeh, D, Castro, C, Montalvo, JLS, Leahy, K, Zhou, Y, Clouser, FA, Siddiqui, M, Leong, N, Goodall, P, Michalowski, M, Ismail, M, Christmas, M, Schrantz, S, Norero, X, Estripeaut, D, Ellis, D, Ashi, K, Dovgin, S, Dixon, A, Li, X, Begeman, I, Heichman, S, Lykins, J, Villalobos-Cerrud, D, Fabrega, L, Mendivil, C, Quijada, MR, Fernández-Pirla, S, de La Guardia, V, Wong, D, de LadrónGuevara, M, Flores, C, Borace, J, García, A, Caballero, N, de Saez, MTM, Politis, M, Ross, S, Dogra, M, Dhamsania, V, Graves, N, Kirchberg, M, Mathur, K, Aue, A, Restrepo, CM, Llanes, A, Guzman, G, Rebollon, A, Boyer, K, Heydemann, P, Noble, AG, Swisher, C, Rabiah, P, Withers, S, Hull, T, Su, C, Blair, M, Latkany, P, Mui, E, Vasconcelos-Santos, DV, Villareal, A, Perez, A, Galvis, CAN, Montes, MV, Perez, NIC, Ramirez, M, Chittenden, C, Wang, E, Lorena Garcia-López, L, Muñoz-Ortiz, J, Rivera-Valdivia, N, Bohórquez-Granados, MC, Castaño-de-la-Torre, G, Padrieu, G, Hernandez, JDV, Celis-Giraldo, D, Acosta Dávila, JA, Torres, E, Oquendo, MM, Arteaga-Rivera, JY, Nicolae, D, Rzhetsky, A, Roizen, N, Stillwaggon, E, Sawers, L, Peyron, F, Wallon, M, Chapey, E, Levigne, P, Charter, C, De Frias, M, Montoya, J, Press, C, Ramirez, R, Contopoulos-Ioannidis, D, Maldonado, Y, Liesenfeld, O, Gomez, C, Wheeler, K, Holfels, E, Frim, D, McLone, D, Penn, R, Cohen, W, Zehar, S, McAuley, J, Limonne, D, Houze, S, Abraham, S, Piarroux, R, Tesic, V, Beavis, K, Abeleda, A, Sautter, M, El Mansouri, B, El Bachir, A, Amarir, F, El Bissati, K, de-la-Torre, A, Britton, G, Motta, J, Ortega-Barria, E, Romero, IL, Meier, P, Grigg, M, Gómez-Marín, J, Rao Kosagisharaf, J, Llorens, XS, Reyes, O & McLeod, R 2022, 'Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors', Current Pediatrics Reports, vol. 10, n.º 2022, pp. 109–124. https://doi.org/10.1007/s40124-022-00265-0

TY - JOUR

T1 - Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

AU - Felín, Mariangela Soberón

AU - Wang, Kanix

AU - Raggi, Catalina

AU - Moreira, Aliya

AU - Pandey, Abhinav

AU - Grose, Andrew

AU - Caballero, Zuleima

AU - Rengifo-Herrera, Claudia

AU - Ramirez, Margarita

AU - Moossazadeh, Davina

AU - Castro, Catherine

AU - Montalvo, José Luis Sanchez

AU - Leahy, Karen

AU - Zhou, Ying

AU - Clouser, Fatima Alibana

AU - Siddiqui, Maryam

AU - Leong, Nicole

AU - Goodall, Perpetua

AU - Michalowski, Morgan

AU - Ismail, Mahmoud

AU - Christmas, Monica

AU - Schrantz, Stephen

AU - Norero, Ximena

AU - Estripeaut, Dora

AU - Ellis, David

AU - Ashi, Kevin

AU - Dovgin, Samantha

AU - Dixon, Ashtyn

AU - Li, Xuan

AU - Begeman, Ian

AU - Heichman, Sharon

AU - Lykins, Joseph

AU - Villalobos-Cerrud, Delba

AU - Fabrega, Lorena

AU - Mendivil, Connie

AU - Quijada, Mario R.

AU - Fernández-Pirla, Silvia

AU - de La Guardia, Valli

AU - Wong, Digna

AU - de LadrónGuevara, Mayrene

AU - Flores, Carlos

AU - Borace, Jovanna

AU - García, Anabel

AU - Caballero, Natividad

AU - de Saez, Maria Theresa Moreno

AU - Politis, Michael

AU - Ross, Stephanie

AU - Dogra, Mimansa

AU - Dhamsania, Vishan

AU - Graves, Nicholas

AU - Kirchberg, Marci

AU - Mathur, Kopal

AU - Aue, Ashley

AU - Restrepo, Carlos M.

AU - Llanes, Alejandro

AU - Guzman, German

AU - Rebollon, Arturo

AU - Boyer, Kenneth

AU - Heydemann, Peter

AU - Noble, A. Gwendolyn

AU - Swisher, Charles

AU - Rabiah, Peter

AU - Withers, Shawn

AU - Hull, Teri

AU - Su, Chunlei

AU - Blair, Michael

AU - Latkany, Paul

AU - Mui, Ernest

AU - Vasconcelos-Santos, Daniel Vitor

AU - Villareal, Alcibiades

AU - Perez, Ambar

AU - Galvis, Carlos Andrés Naranjo

AU - Montes, Mónica Vargas

AU - Perez, Nestor Ivan Cardona

AU - Ramirez, Morgan

AU - Chittenden, Cy

AU - Wang, Edward

AU - Lorena Garcia-López, Laura

AU - Muñoz-Ortiz, Juliana

AU - Rivera-Valdivia, Nicolás

AU - Bohórquez-Granados, María Cristina

AU - Castaño-de-la-Torre, Gabriela

AU - Padrieu, Guillermo

AU - Hernandez, Juan David Valencia

AU - Celis-Giraldo, Daniel

AU - Acosta Dávila, John Alejandro

AU - Torres, Elizabeth

AU - Oquendo, Manuela Mejia

AU - Arteaga-Rivera, José Y.

AU - Nicolae, Dan

AU - Rzhetsky, Andrey

AU - Roizen, Nancy

AU - Stillwaggon, Eileen

AU - Sawers, Larry

AU - Peyron, Francois

AU - Wallon, Martine

AU - Chapey, Emanuelle

AU - Levigne, Pauline

AU - Charter, Carmen

AU - De Frias, Migdalia

AU - Montoya, Jose

AU - Press, Cindy

AU - Ramirez, Raymund

AU - Contopoulos-Ioannidis, Despina

AU - Maldonado, Yvonne

AU - Liesenfeld, Oliver

AU - Gomez, Carlos

AU - Wheeler, Kelsey

AU - Holfels, Ellen

AU - Frim, David

AU - McLone, David

AU - Penn, Richard

AU - Cohen, William

AU - Zehar, Samantha

AU - McAuley, James

AU - Limonne, Denis

AU - Houze, Sandrine

AU - Abraham, Sylvie

AU - Piarroux, Raphael

AU - Tesic, Vera

AU - Beavis, Kathleen

AU - Abeleda, Ana

AU - Sautter, Mari

AU - El Mansouri, Bouchra

AU - El Bachir, Adlaoui

AU - Amarir, Fatima

AU - El Bissati, Kamal

AU - de-la-Torre, Alejandra

AU - Britton, Gabrielle

AU - Motta, Jorge

AU - Ortega-Barria, Eduardo

AU - Romero, Isabel Luz

AU - Meier, Paul

AU - Grigg, Michael

AU - Gómez-Marín, Jorge

AU - Rao Kosagisharaf, Jagannatha

AU - Llorens, Xavier Sáez

AU - Reyes, Osvaldo

AU - McLeod, Rima

PY - 2022/6/22

Y1 - 2022/6/22

N2 - Purpose of Review: Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings: Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies to Toxoplasma and risk factors, were reviewed. Summary: Screening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panamá estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasma antibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overall Toxoplasma seroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis and Toxoplasma infection.

AB - Purpose of Review: Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings: Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies to Toxoplasma and risk factors, were reviewed. Summary: Screening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panamá estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasma antibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overall Toxoplasma seroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis and Toxoplasma infection.

UR - http://www.scopus.com/inward/record.url?scp=85132367254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132367254&partnerID=8YFLogxK

U2 - 10.1007/s40124-022-00265-0

DO - 10.1007/s40124-022-00265-0

M3 - Review article

C2 - 37744780

AN - SCOPUS:85132367254

SN - 2167-4841

VL - 10

SP - 109

EP - 124

JO - Current Pediatrics Reports

JF - Current Pediatrics Reports

IS - 2022

ER -

Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

Resumen

Áreas temáticas de ASJC Scopus

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto